Pages that link to "Q37412425"

The following pages link to Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex (Q37412425):

Displaying 50 items.

• Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies (Q24293092) (← links)
• Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor (Q24557336) (← links)
• Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences (Q24558671) (← links)
• The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction (Q24564709) (← links)
• ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction (Q24567518) (← links)
• A humanized antibody that binds to the interleukin 2 receptor (Q24600912) (← links)
• Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins (Q24652745) (← links)
• Identification and purification of a receptor on macrophages for the dengue virus-induced suppressor cytokine (Q27473551) (← links)
• Structural basis of immunosuppression by the therapeutic antibody daclizumab (Q27664283) (← links)
• The implications of subunit interactions for the structure of the T cell receptor-CD3 complex (Q28306677) (← links)
• Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys (Q28365417) (← links)
• The lipid A region of lipopolysaccharides from Rhizobiaceae activates bone marrow granulocytes from lipopolysaccharide-hyporesponsive C3H/HeJ and C57BL/10ScCr mice (Q30933560) (← links)
• Interleukin-2 stimulation of blood mononuclear cells from patients with inflammatory bowel disease (Q33348482) (← links)
• Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli (Q33560732) (← links)
• Human thymic epithelial cells directly induce activation of autologous immature thymocytes (Q33570886) (← links)
• Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation (Q33582617) (← links)
• Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro (Q33645011) (← links)
• Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2 (Q33648545) (← links)
• A 100-kilodalton protein is associated with the murine interleukin 2 receptor: biochemical evidence that p100 is distinct from the alpha and beta chains (Q33649153) (← links)
• Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice (Q33822962) (← links)
• Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes (Q33838426) (← links)
• Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes (Q33847436) (← links)
• Fluorinated 4-quinolones induce hyperproduction of interleukin 2. (Q33850832) (← links)
• Exogenous cyclic AMP, cholera toxin, and endotoxin induce expression of the lipopolysaccharide receptor CD14 in murine bone marrow cells: role of purinoreceptors. (Q33998018) (← links)
• Down-modulation of L-selectin by lipopolysaccharide is not required for lipopolysaccharide-induced expression of CD14 in mouse bone marrow granulocytes (Q34008208) (← links)
• Advances in interleukin 2 receptor targeted treatment (Q34071328) (← links)
• Human eosinophils express functional interleukin 2 receptors (Q34197541) (← links)
• Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor (Q34225129) (← links)
• Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids (Q34242456) (← links)
• Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors (Q34255250) (← links)
• Identification and comparative expression analysis of interleukin 2/15 receptor β chain in chickens infected with E. tenella (Q34291178) (← links)
• The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat (Q34317298) (← links)
• The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells (Q34334821) (← links)
• Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease (Q34375240) (← links)
• Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin (Q34392462) (← links)
• Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors (Q34609794) (← links)
• The IL-2/IL-15 receptor systems: targets for immunotherapy (Q34630134) (← links)
• Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex (Q34632128) (← links)
• The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation (Q34659968) (← links)
• Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits (Q35170452) (← links)
• The Interleukin 2 Receptor in the Hypereosinophilic Syndrome (Q35219348) (← links)
• The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells (Q35329030) (← links)
• Cytokines in inflammatory bowel disease (Q35556914) (← links)
• Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells (Q35585247) (← links)
• Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2 (Q35603192) (← links)
• Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors (Q35811149) (← links)
• Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells (Q35811833) (← links)
• Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. (Q35833881) (← links)
• Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus (Q35838192) (← links)
• Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis (Q35948618) (← links)